Cobitus-P 750mcg/75mg Capsule
Marketer
Ventus Pharmaceuticals Pvt Ltd
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Cobitus-P 750mcg/75mg Capsule
Gabapentinoid PRN 750mcg/75mg capsules are a prescription medication indicated for neuropathic pain management. Its mechanism involves modulating nerve cell calcium channel activity, reducing pain signals. This medication also offers neuroprotective effects, promoting nerve fiber repair and potentially healing damaged nerve cells. Gabapentinoid PRN 750mcg/75mg capsules are administered orally, with or without food, ideally before sleep. Consistent daily timing is recommended to maintain therapeutic blood levels. Adhere strictly to the prescribed dosage and duration, as this medication has addictive potential. Missed doses should be taken promptly upon recall. Complete the entire treatment course, even with symptom improvement. Abrupt cessation should be avoided without consulting your physician. Common adverse reactions may include upper respiratory tract infection, increased appetite, elevated mood, tremors, visual blurring, dry mouth, vertigo, and somnolence. Avoid activities requiring alertness until the medication's effects are known. Side effects are typically mild and resolve over time. Weight gain is possible; regular exercise and a balanced diet are recommended for mitigation. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Full disclosure of all other medications is crucial, as interactions may impact efficacy or alter the drug's action. Inform your physician of pregnancy, pregnancy plans, or breastfeeding.
Uses of Cobitus-P 750mcg/75mg Capsule
Managing neuropathic pain
Major Benefits of Cobitus-P 750mcg/75mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cobitus-P 750mcg/75mg Capsules. These capsules can be administered with or without food, though consistent timing is recommended.
Common Side effects of Cobitus-P 750mcg/75mg Capsule:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Cobitus-P 750mcg/75mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cobitus-P 750mcg/75mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.
How Cobitus-P 750mcg/75mg Capsule works:
Cobitus-P 750mcg/75mg capsules contain methylcobalamin and pregabalin, working synergistically to alleviate neuropathic pain. Methylcobalamin, a B vitamin variant, supports myelin sheath production, protecting and repairing nerve fibers. Pregabalin, an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Taking Cobitus-P 750mcg/75mg capsules with alcohol may result in pronounced sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Cobitus-P 750mcg/75mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Cobitus-P 750mcg/75mg capsules while breastfeeding is likely inadvisable. Scant available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Cobitus-P 750mcg/75mg Capsules might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Cobitus-P 750mcg/75mg Capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Cobitus-P 750mcg/75mg capsules in patients with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Cobitus-P 750mcg/75mg Capsule :
Should you forget to take your Cobitus-P 750mcg/75mg Capsule, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cobitus-P 750mcg/75mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
3,018 People bought this recently